LC method for the quantitative determination of oxaprozin and its impurities in the bulk drug

Journal of Pharmaceutical and Biomedical Analysis

Volumn 22, Issue 4, 2000, Pages 651-659

  Reddy, K V S R Krishna ^a   Rao, D Sreenivas ^a   Vyas, K ^a   Reddy, G Om ^a  

^a DR REDDY S RESEARCH FOUNDATION   (India)

Author keywords

Gradient liquid chromatography; Impurities; LOD; LOQ; Oxaprozin

Indexed keywords

OXAPROZIN; OXAZOLE DERIVATIVE;

ACCURACY; CONFERENCE PAPER; DRUG DETERMINATION; DRUG IMPURITY; DRUG PURIFICATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, LIQUID; DRUG CONTAMINATION; PROPIONIC ACIDS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS;

EID: 0141477031     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(99)00305-2     Document Type: Article

References (12)

1. Merck Index, 11th Ed., 6879, p. 1095.
2. Hubsher J.A., Northington R.S., Walker B.R. Arthritis Rheum. 26:1982;S117.
3. Brown K., Cavalla J.F., Green D., Wilson A.B. Nature. 219:1968;164.
4. Pierce D.M. Xenobiotica. 11:1981;857-862.
5. Pharmacoepia of Japan, XIII, 1996.
6. Janssen F.W., Kirkman S.K., Knowles J.A., Ruelius H.W. Drug Metab. Dispos. 6:1978;465.
7. McHugh L.S., Kirkman S.K., Knowles J.A., John A. J. Pharm. Sci. 69:1980;794-796.
8. Matlis R., Greenblat D.J. J. Chromatogr. 310:1984;445-449.
9. Kurowski M., Thabe H. Agents Actions. 27:1989;458-460.
10. Chiang S.T., Knowles J.A., Hubsher J.A., Ruelius H.W., Walker B.R. J. Clin. Pharmacol. 24:1984;381-385.
11. Ibrahim F.B. J. Liq. Chromatogr. 18:1995;2621-2633.
12. Houck A., Thomas S., Ellison D.K. Talanta. 40:1993;491-494.